[PBBANK] QoQ TTM Result on 30-Jun-2016 [#2]

Announcement Date
28-Jul-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- 1.16%
YoY- 7.6%
View:
Show?
TTM Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 20,123,624 20,102,740 19,947,703 19,831,126 19,588,548 19,181,550 18,781,089 4.70%
PBT 6,533,946 6,554,032 6,619,097 6,674,649 6,654,275 6,491,395 6,200,897 3.54%
Tax -1,246,228 -1,286,597 -1,343,760 -1,434,861 -1,472,178 -1,370,156 -1,320,488 -3.78%
NP 5,287,718 5,267,435 5,275,337 5,239,788 5,182,097 5,121,239 4,880,409 5.48%
-
NP to SH 5,225,066 5,206,875 5,216,521 5,179,766 5,120,423 5,062,152 4,823,705 5.46%
-
Tax Rate 19.07% 19.63% 20.30% 21.50% 22.12% 21.11% 21.30% -
Total Cost 14,835,906 14,835,305 14,672,366 14,591,338 14,406,451 14,060,311 13,900,680 4.43%
-
Net Worth 34,196,617 34,213,222 32,826,175 32,443,500 31,111,671 31,230,991 29,640,055 9.99%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 2,239,666 2,239,666 2,239,666 2,239,666 2,162,539 2,162,436 2,123,821 3.60%
Div Payout % 42.86% 43.01% 42.93% 43.24% 42.23% 42.72% 44.03% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 34,196,617 34,213,222 32,826,175 32,443,500 31,111,671 31,230,991 29,640,055 9.99%
NOSH 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 3,882,138 0.00%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 26.28% 26.20% 26.45% 26.42% 26.45% 26.70% 25.99% -
ROE 15.28% 15.22% 15.89% 15.97% 16.46% 16.21% 16.27% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 521.14 520.59 516.58 513.56 507.28 496.74 486.37 4.70%
EPS 135.31 134.84 135.09 134.14 132.60 131.09 124.92 5.46%
DPS 58.00 58.00 58.00 58.00 56.00 56.00 55.00 3.60%
NAPS 8.8558 8.8601 8.5009 8.4018 8.0569 8.0878 7.6758 9.99%
Adjusted Per Share Value based on latest NOSH - 3,882,138
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 103.67 103.57 102.77 102.17 100.92 98.82 96.76 4.70%
EPS 26.92 26.82 26.87 26.69 26.38 26.08 24.85 5.47%
DPS 11.54 11.54 11.54 11.54 11.14 11.14 10.94 3.62%
NAPS 1.7617 1.7626 1.6911 1.6714 1.6028 1.609 1.527 9.99%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 19.90 19.72 19.82 19.40 18.78 18.52 17.52 -
P/RPS 3.82 3.79 3.84 3.78 3.70 3.73 3.60 4.02%
P/EPS 14.71 14.62 14.67 14.46 14.16 14.13 14.03 3.20%
EY 6.80 6.84 6.82 6.91 7.06 7.08 7.13 -3.10%
DY 2.91 2.94 2.93 2.99 2.98 3.02 3.14 -4.94%
P/NAPS 2.25 2.23 2.33 2.31 2.33 2.29 2.28 -0.87%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 20/04/17 02/02/17 20/10/16 28/07/16 20/04/16 03/02/16 22/10/15 -
Price 19.92 20.14 19.80 19.56 19.02 18.38 18.64 -
P/RPS 3.82 3.87 3.83 3.81 3.75 3.70 3.83 -0.17%
P/EPS 14.72 14.94 14.66 14.58 14.34 14.02 14.92 -0.89%
EY 6.79 6.70 6.82 6.86 6.97 7.13 6.70 0.89%
DY 2.91 2.88 2.93 2.97 2.94 3.05 2.95 -0.90%
P/NAPS 2.25 2.27 2.33 2.33 2.36 2.27 2.43 -4.99%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment